Fully implantable and battery-free wireless optoelectronic system for modulable cancer therapy and real-time monitoring DOI Creative Commons

Kiho Kim,

In Sik Min, Tae Hee Kim

et al.

npj Flexible Electronics, Journal Year: 2023, Volume and Issue: 7(1)

Published: Aug. 28, 2023

Abstract Photodynamic therapy (PDT) is attracting attention as a next-generation cancer treatment that can selectively destroy malignant tissues, exhibit fewer side effects, and lack pain during treatments. Implantable PDT systems have recently been developed to resolve the issues of bulky expensive conventional implement continuous repetitive treatment. Existing implantable systems, however, are not able perform multiple functions simultaneously, such modulating light intensity, measuring, transmitting tumor-related data, resulting in complexity Here, we introduce flexible fully wireless optoelectronic system capable effective by fusing hyperthermia enabling tumor size monitoring real-time. This exploits micro inorganic light-emitting diodes (μ-LED) emit with wavelength 624 nm, designed affect surrounding normal tissues utilizing programmable intensity μ-LED precisely Si phototransistor long-term implantation (2–3 weeks). The superiority simultaneous capabilities our operated power data transmissions cell phone was confirmed through vitro experiments, ray-tracing simulation results, xenograft mouse model vivo. all-in-one single for offers opportunities only enable tumors located deep tissue but also precise

Language: Английский

Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy DOI
Kun‐Xu Teng, Li‐Ya Niu, Qing‐Zheng Yang

et al.

Journal of the American Chemical Society, Journal Year: 2023, Volume and Issue: 145(7), P. 4081 - 4087

Published: Feb. 13, 2023

The highly oxygen-dependent nature of photodynamic therapy (PDT) limits its therapeutic efficacy against hypoxic solid tumors in clinics, which is an urgent problem to be solved. Herein, we develop oxygen-independent supramolecular agent that produces hydroxyl radical (•OH) by oxidizing water the presence intracellularly abundant pyruvic acid under oxygen-free conditions. A fluorene-substituted BODIPY was designed as electron donor and coassembled with perylene diimide acceptor form quadruple hydrogen-bonded agent. Detailed mechanism studies reveal intermolecular transfer charge separation upon light irradiation result efficient generation ion pairs. Under conditions, cationic radicals directly oxidize generate cytotoxic •OH, anionic electrons acid, realizing catalytic cycle. Thus, this exhibited superb photocytotoxicity even severe environments excellent vivo antitumor on HeLa-bearing mouse models. This work provides a strategy for constructing agents, opens up avenue effective PDT tumors.

Language: Английский

Citations

213

BODIPY as a Multifunctional Theranostic Reagent in Biomedicine: Self‐Assembly, Properties, and Applications DOI
Hong‐Bo Cheng,

Xiaoqiao Cao,

Shuchun Zhang

et al.

Advanced Materials, Journal Year: 2022, Volume and Issue: 35(18)

Published: Nov. 18, 2022

Abstract The use of boron dipyrromethene (BODIPY) in biomedicine is reviewed. To open, its synthesis and regulatory strategies are summarized, inspiring cutting‐edge work post‐functionalization highlighted. A brief overview assembly model BODIPY then provided: introduced as a promising building block for the formation single‐ multicomponent self‐assembled systems, including nanostructures suitable aqueous environments, thereby showing great development potential supramolecular applications. frontier progress biomedical application thereafter described, supported by examples frontiers applications BODIPY‐containing smart materials: it mainly involves materials based on blocks their assemblies fluorescence bioimaging, photoacoustic imaging, disease treatment photodynamic therapy, photothermal immunotherapy. Lastly, not only current status family field but also challenges worth considering summarized. At same time, insights into future prospects biomedically applicable provided.

Language: Английский

Citations

143

Engineering of BODIPY-based theranostics for cancer therapy DOI
Zhiqiang Mao, Ji Hyeon Kim, Jieun Lee

et al.

Coordination Chemistry Reviews, Journal Year: 2022, Volume and Issue: 476, P. 214908 - 214908

Published: Nov. 7, 2022

Language: Английский

Citations

101

Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy DOI
Sisi Wang, Lizhi Gai, Yuncong Chen

et al.

Chemical Society Reviews, Journal Year: 2024, Volume and Issue: 53(8), P. 3976 - 4019

Published: Jan. 1, 2024

This review focuses on the design strategy, spectroscopic characteristics, and functionalization of mitochondrion-targeted BODIPY dyes, providing an overview these dyes for bioimaging photodynamic therapy.

Language: Английский

Citations

54

Photo‐Induced Disproportionation‐Mediated Photodynamic Therapy: Simultaneous Oxidation of Tetrahydrobiopterin and Generation of Superoxide Radicals DOI
Kun‐Xu Teng, Dongsheng Zhang,

Bin‐Kai Liu

et al.

Angewandte Chemie International Edition, Journal Year: 2024, Volume and Issue: 63(12)

Published: Jan. 23, 2024

We herein present an approach of photo-induced disproportionation for preparation Type-I photodynamic agents. As a proof concept, BODIPY-based photosensitizers were rationally designed and prepared. The intermolecular electron transfer between homotypic chromophores leads to the reaction, resulting in formation charged intermediates, cationic anionic radicals. radicals efficiently oxidize cellularimportant coenzyme, tetrahydrobiopterin (BH

Language: Английский

Citations

43

Enhancing Fractionated Cancer Therapy: A Triple-Anthracene Photosensitizer Unleashes Long-Persistent Photodynamic and Luminous Efficacy DOI
Youjuan Wang,

Hengxin Shen,

Zhe Li

et al.

Journal of the American Chemical Society, Journal Year: 2024, Volume and Issue: 146(9), P. 6252 - 6265

Published: Feb. 20, 2024

Conventional photodynamic therapy (PDT) is often limited in treating solid tumors due to hypoxic conditions that impede the generation of reactive oxygen species (ROS), which are critical for therapeutic efficacy. To address this issue, a fractionated PDT protocol has been suggested, wherein light irradiation administered stages separated by dark intervals permit recovery during these breaks. However, current photosensitizers used incapable sustaining ROS production intervals, leading suboptimal outcomes (Table S1). circumvent drawback, we have synthesized novel photosensitizer based on triple-anthracene derivative designed prolonged generation, even after cessation exposure. Our study reveals unique action derivatives, facilitating direct and effective disruption biomolecules significantly improving efficacy S2). Moreover, existing lack imaging capabilities monitoring, constraints fine-tuning parameters also serves as an afterglow agent, emitting sustained luminescence postirradiation. This function allows precise optimization between sessions aids determining timing subsequent irradiation, thus enabling meticulous control over parameters. Utilizing our photosensitizer, formulated regimen effectively eliminates orthotopic pancreatic tumors. investigation highlights promise employing long-persistent activity advanced approaches overcome limitations tumor treatment.

Language: Английский

Citations

33

Recent advances in organelle-targeted organic photosensitizers for efficient photodynamic therapy DOI
Musa Dirak, Cansu M. Yenici, Safacan Kölemen

et al.

Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 506, P. 215710 - 215710

Published: Feb. 20, 2024

Language: Английский

Citations

26

Tumor-microenvironment-activatable organic phototheranostic agents for cancer therapy DOI

Shuang Zeng,

Zhihan Guo,

Yifu Hao

et al.

Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 509, P. 215786 - 215786

Published: March 20, 2024

Language: Английский

Citations

26

Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single‐Component Organic Phototherapeutic Agents DOI Creative Commons
Laiping Fang,

Zengzhen Chen,

Jianan Dai

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 10, 2025

Abstract Photodynamic therapy (PDT) and photothermal (PTT) have emerged as promising treatment options, showcasing immense potential in addressing both oncologic nononcologic diseases. Single‐component organic phototherapeutic agents (SCOPAs) offer advantages compared to inorganic or multicomponent nanomedicine, including better biosafety, lower toxicity, simpler synthesis, enhanced reproducibility. Nonetheless, how further improve the therapeutic effectiveness of SCOPAs remains a challenging research area. This review delves deeply into strategies performance PDT PTT by optimizing structural design SCOPAs. These encompass augmenting reactive oxygen species (ROS) generation, mitigating dependence, elevating light absorption capacity, broadening region, enhancing conversion efficiency (PCE). Additionally, this also underscores ideal for developing with balanced PTT. Furthermore, synergies are highlighted between other modalities such ferroptosis, gas therapy, chemotherapy, immunotherapy. By providing comprehensive analysis these strategies, aspires serve valuable resource clinicians researchers, facilitating wider application advancement SCOPAs‐mediated

Language: Английский

Citations

3

Unique Double Intramolecular and Intermolecular Exciton Coupling in Ethene‐Bridged aza‐BODIPY Dimers for High‐Efficiency Near‐Infrared Photothermal Conversion and Therapy DOI
Xing Guo,

Jinming Yang,

Mao Li

et al.

Angewandte Chemie International Edition, Journal Year: 2022, Volume and Issue: 61(44)

Published: Sept. 13, 2022

Spatial electronic communications of chromophores are both theoretically and practically fascinating. Despite intramolecular or intermolecular exciton coupling was observed in multichromophoric oligomers J-aggregates, respectively, it is unusual that they occur the same molecule. Herein, ethene-bridged aza-BODIPY dimers with splitting have been developed. By encapsulating dimer into F-127 polymer, J-type aggregated nanoparticles were produced, which showed obvious dramatically redshifted absorption emission peaks at 936 1003 nm, respectively. The fabricated nanoagents high photothermal conversion ability (η=60.3 %) ultra-photostable, leading to complete tumor ablation 915 nm laser irradiation. This phototherapeutic nanoplatform through modulating intra- couplings a valuable paradigm for developing agents treatment.

Language: Английский

Citations

62